Pemetrexed-Based Chemotherapy Is Inferior to Pemetrexed-Free Regimens in Thyroid Transcription Factor 1 (TTF-1)-Negative, EGFR/ALK-Negative Lung Adenocarcinoma: A Propensity Score Matched Pairs Analysis
Titel:
Pemetrexed-Based Chemotherapy Is Inferior to Pemetrexed-Free Regimens in Thyroid Transcription Factor 1 (TTF-1)-Negative, EGFR/ALK-Negative Lung Adenocarcinoma: A Propensity Score Matched Pairs Analysis
Auteur:
Frost, Nikolaj Zhamurashvili, Tamar von Laffert, Maximilian Klauschen, Frederick Ruwwe-Glösenkamp, Christoph Raspe, Matthias Brunn, Matthias Ochsenreither, Sebastian Temmesfeld-Wollbrück, Bettina Suttorp, Norbert Grohé, Christian Witzenrath, Martin